Sphera Funds Management Ltd. Ovid Therapeutics Inc. Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 10, 2018
SELL
$6.53 - $9.82 $1.18 Million - $1.77 Million
-180,674 Closed
0 $0
Q4 2017

Feb 12, 2018
SELL
$6.12 - $12.31 $765,000 - $1.54 Million
-125,000 Reduced 40.89%
180,674 $1.78 Million
Q3 2017

Nov 09, 2017
BUY
$5.32 - $9.77 $1.63 Million - $2.99 Million
305,674
305,674 $2.62 Million

Others Institutions Holding OVID

# of Institutions
75
Shares Held
39M
Call Options Held
37.4K
Put Options Held
500
View Full List

About Ovid Therapeutics Inc.

OVID Quotes by TradingView
  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $66.9M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email